Table 3.

Comparison of classifier scores in patients who reached an endpoint compared to those who did not

Endpoint	Yes	No	p value
30% decline eGFR (29 events)	0.239 ± 0.414	0.228 ± 0.390	0.886
Transition micro to macroalbuminuria (19 events)	0.354 ± 0.238	0.145 ± 0.406	*0.036
Cardiovascular event (31 events)	0.331 ± 0.389	0.216 ± 0.405	0.156
Mortality (20 events)	0.438 ± 0.355	0.208 ± 0.403	*0.017

We defined the following endpoints for analysis: (1) All-cause mortality. (2) CV events. (3) 30% decline in eGFR. (4) Transition from micro to macroalbuminuria. With regard to the latter, there were 19 patients who progressed and 73 who remained microalbuminuric or regressed; we did not analyse data on people who were macroalbuminuric at baseline. Data are mean ± SD, p value of < 0.05 deemed statistically significant. Comparisons are by 2 sample t test. p < 0.05 and * denote statistical significance